自从1992年建立以来，Trinity Biotech 公司继续积极从事于诊断行业，目标是成为一个*者。强有机的增长和不断进步的战略模式见证了公司的荣誉。 迄今为止Trinity Biotech 公司组装过的组合已经超过了400种。
专业发展于诊断器材的销售和制造， 三一生物技术的持续成功依赖于公司始终如一的质量标准。
Trinity Biotech公司生产测试套件主要用于
临床实验室和临时诊断市场细分的探测传染病、性传播疾病、自身免疫和血红蛋白疾患、探测、监视和控制糖尿病方面。
公司也是生命科学行业理重要的原材料供应商。
从纳斯达克交易所获悉,三一生物技术产品已经横跨欧洲和美国热销于世界上75个国家。通过自身的技能和网络销售能力已经与世界各地的分销商形成了战略伙伴关系。
TRINITY 公司是的临床诊断试剂及临床免疫类仪器生产供应商，*纳斯达克上市的医药企业。公司商业总部位于爱尔兰都柏林，在纽约Jamston, California,,英国warehouse, 德国，加拿大，瑞典均设有生产基地。自1992年成立以来，已在收购十多家医药生物公司。其产品范围包括自身免疫性疾病的诊断，激素类诊断试剂，药物监测，性传播疾病和传染病血清学诊断，及临床血液部门检测（Sigma）,临床凝血检测（Biopool）。
Trinity Biotech的制造设备基地如下：
布雷,爱尔兰-急流,传染病
卡尔斯巴德,美国-传染病,免疫印迹,现阶段的发展
阿克顿,美国-原材料供应的研究和诊断行业
詹姆斯敦,美国-传染病——酶免疫测定（EIA）
堪萨斯城,美国–基于液相色谱Boronate亲和力糖尿病诊断
Glucose-6-Phosphate Dehydrogenase （G-6-PDH） is an X-linked disorder is the most common type of haemolytic anaemia due to an intrinsic red cell enzyme defect.
Males who inherit an abnormal gene are invariably affected. Heterozygote females usually have approximay 50% G6PD enzyme activity; the random Lyonisation of X chromosomes means that rarely carrier females may be severely affected. It is most common in the Mediterranean, the Middle East, South East Asia and West Africa. It is rare among Caucasians.
METHOD Ultraviolet, Kinetic （quantitative）
PRINCIPLE
The rate of formation of NADPH is proportional to the G-6-PDH activity is measured spectrophotometrically as an increase in absorbance at 340nm.
DIAGNOSTIC IMPLICATIONS Presentation is usually with an acute episode of intravascular haemolysis on exposure to certain drugs, infection or acute illness. Mediterranean forms may present with neonatal jaundice. The condition is also known as favism as sudden haemolysis may be precipitated by the ingestion of fava beans – Vicia faba. The deficiency is generally less severe in Africans and favism is rare in this population.
PRODUCTBRANDCODEKIT
G-6-PDH kit （50 assays）Trinity Biotech345-BMaximum Assays: 50
G-6-PDH kit （20 assays）Trinity Biotech345-AMaximum Assays: 20
G-6-PDH Red Cell Lysing ReagentTrinity BiotechR11294×25 ml